News

Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023

Lee A. Shapiro, Clover Audit Committee Chair, will lead the search for the next Clover CFOFRANKLIN, Tenn., Dec. 21, 2023…

2 years ago

Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants

AUSTIN, TX and DURHAM, NC, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “company”) (NASDAQ: STTK),…

2 years ago

4DMT Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for 4D-150 Genetic Medicine for Intravitreal Treatment of Wet AMD, the First RMAT Designation in Wet AMD

Designation follows interim Phase 1 PRISM clinical data for 4D-150 that demonstrated an encouraging safety, tolerability and clinical activity profile…

2 years ago

Vaxart Announces Last Subject Dosed in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers

On track to report topline data by the end of 2024 SOUTH SAN FRANCISCO, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE)…

2 years ago

SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools

Combination Builds Scale and Accelerates Path to Profitability, Unlocking Significant Potential Value for SomaLogic Stockholders Madryn’s Concerns are Not Based…

2 years ago

Longeveron Announces $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

MIAMI, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing…

2 years ago

Senzime Secures Initial TetraGraph Order from Major New York Metropolitan Region University Hospital Group

UPPSALA, SWEDEN / ACCESSWIRE / December 21, 2023 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in algorithm-based patient monitoring solutions,…

2 years ago

IRLAB’s Drug Candidate IRL757 is Phase I Ready

GOTHENBURG, SWEDEN / ACCESSWIRE / December 21, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, December 21, 2023 - IRLAB…

2 years ago

Verisante Technology, Inc. Announces 2023 AGM Results

VANCOUVER, BC / ACCESSWIRE / December 20, 2023 / Verisante Technology, Inc. (TSXV:VER.H) (the "Company") is pleased to announce that…

2 years ago

MyndTec Inc. Completes Second Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 20, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in…

2 years ago